A Canadian biopharma stock produced a healthy gain Monday following a U.S. patent announcement. Here’s some small stocks making big moves on Monday, June 17, 2019 (as of 4 pm EST):
Sirona Biochem Corp. (TSXV:SBM), a Canadian biopharma stock, jumped 9% to $0.48 on Monday after announcing that the patent for TFC-1067 entitled “Gem Difluorocompounds as Depigmenting or Lightening Agents” was granted in the United States and will be published in the official database in the coming month.
As well, shares of Street Capital Group Inc. (TSX:SCB) surged 32% to $0.66 as the financial services company said it has agreed to be acquire by RFA Capital Holdings Inc. for $0.68 per share in cash, or a total consideration of approximately $85 million.
Liberty Defense Holdings, Ltd. (TSXV:SCAN), meanwhile, reported that it has signed a Memorandum of Understanding with the German soccer team FC Bayern München, to beta test HEXWAVE. Liberty Defense stock moved up as much as 4% following the announcement.
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
Sirona Biochem Corp. (TSXV:SBM), a Canadian biopharma stock, jumped 9% to $0.48 on Monday after announcing that the patent for TFC-1067 entitled “Gem Difluorocompounds as Depigmenting or Lightening Agents” was granted in the United States and will be published in the official database in the coming month.
